(Q38009670)

26 August 2017

title

Urate in Parkinson's disease: more than a biomarker? (English)

1 reference

26 August 2017

0 references

1 reference

Michael A Schwarzschild

series ordinal

3

object named as

Michael A Schwarzschild

1 reference

26 August 2017

Xiqun Chen

1

1 reference

26 August 2017

Guanhui Wu

series ordinal

2

1 reference

26 August 2017

publication date

1 August 2012

1 reference

Current Neurology and Neuroscience Reports

26 August 2017

published in

1 reference

26 August 2017

volume

12

1 reference

26 August 2017

issue

4

1 reference

26 August 2017

page(s)

367-375

1 reference

Potential oxidative pathways of brain catecholamines

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

The origins of oxidant stress in Parkinson's disease and therapeutic strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Oxidative and nitrosative stress in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Neuroprotection trials in Parkinson's disease: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

A double-blind, delayed-start trial of rasagiline in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Clinical trials for neuroprotection in Parkinson's disease: overcoming angst and futility?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Pathophysiological roles for purines: adenosine, caffeine and urate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Multiple roles for nicotine in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Peroxidase properties of extracellular superoxide dismutase: role of uric acid in modulating in vivo activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: implications for uncoupling endothelial nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Biomarkers of antioxidant capacity in the hydrophilic and lipophilic compartments of human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Translational stroke research of the combination of thrombolysis and antioxidant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

The role of uric acid in protection against peroxynitrite-mediated pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

On the significance of brain extracellular uric acid detected with in-vivo monitoring techniques: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Uric acid is reduced in the substantia nigra in Parkinson's disease: effect on dopamine oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Serum uric acid levels in patients with Parkinson's disease: their relationship to treatment and disease duration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Metabolomic profiling to develop blood biomarkers for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

The urate and xanthine concentrations in the cerebrospinal fluid in patients with vascular dementia of the Binswanger type, Alzheimer type dementia, and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Plasma urate and risk of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

The risk of Parkinson disease associated with urate in a community-based cohort of older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Diet, urate, and Parkinson's disease risk in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Gout and the risk of Parkinson's disease: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Plasma urate and Parkinson's disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Urate as a predictor of the rate of clinical decline in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Serum urate as a predictor of clinical and radiographic progression in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Serum urate and probability of dopaminergic deficit in early "Parkinson's disease".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Uric acid associates with cognition in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Uric acid and cognition in Parkinson's disease: a follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Serum uric acid and cognitive function and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Hypouricemia, abnormal renal tubular urate transport, and plasma natriuretic factor(s) in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Plasma antioxidant status, immunoglobulin g oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

The relationship between uric acid levels and Huntington's disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Uric acid levels predict survival in men with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Plasma urate and progression of mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Serum uri acid: neuroprotection in thrombolysis. The Bergen NORSTROKE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Inosine induces axonal rewiring and improves behavioral outcome after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Inosine reduces ischemic brain injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Uric acid protects against secondary damage after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Caffeine and uric acid mediate glutathione synthesis for neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induces apoptosis in mouse nigrostriatal glia. Relevance to nigral neuronal death and striatal neurochemical changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Changes in uric acid during acute infusion of MPP+, 6-OHDA, and FeCl3. A microdialysis study in the substantia nigra of the guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Impairment of the ability of the injured aged brain in elevating urate and ascorbate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Dopamine-induced apoptosis is mediated by oxidative stress and Is enhanced by cyanide in differentiated PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

21 January 2018

Uric acid and evolution.

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Altered uric acid levels and disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Multifactorial index of cardiac risk in noncardiac surgical procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Biomarker research in Parkinson's disease: objective measures needed for patient stratification in future cause-directed trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Variation in the Uric Acid Transporter Gene SLC2A9 and Its Association with AAO of Parkinson’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Serum uric acid levels and the risk of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

Protective effects of urate against 6-OHDA-induced cell injury in PC12 cells through antioxidant action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-012-0282-7

6-Hydroxydopamine, a new oxidation mechanism

21 January 2018

1 reference

12 December 2020

Gout and risk of Parkinson disease: A prospective study

1 reference

12 December 2020

Association of serum uric acid levels with the progression of Parkinson's disease in Chinese patients

1 reference

12 December 2020

Conservation of vitamin C by uric acid in blood

1 reference

12 December 2020

An exploratory study of serum urate levels in patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community-based survey

1 reference

12 December 2020

Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra.

1 reference

12 December 2020

Protective effects of uric acid on nigrostriatal system injury induced by 6-hydroxydopamine in rats

1 reference

12 December 2020

Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?

1 reference

12 December 2020

Protection against peroxynitrite-dependent tyrosine nitration and alpha 1-antiproteinase inactivation by ascorbic acid. A comparison with other biological antioxidants

1 reference

12 December 2020

Low plasma uric acid level in Parkinson's disease

1 reference

12 December 2020

Serum and cerebrospinal fluid uric acid levels in lewy body disorders: associations with disease occurrence and amyloid-β pathway.

1 reference

12 December 2020

Case-control study of markers of oxidative stress and metabolism of blood iron in Parkinson's disease

1 reference

12 December 2020

Why have we failed to achieve neuroprotection in Parkinson's disease?

1 reference

12 December 2020

Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones

1 reference

12 December 2020

Astroglia-mediated effects of uric acid to protect spinal cord neurons from glutamate toxicity

1 reference

12 December 2020

Low uric acid levels in serum of patients with ALS: further evidence for oxidative stress?

1 reference

12 December 2020

[Study on uric acid and the related factors associated with cognition in the patients with Parkinson's disease].

1 reference

12 December 2020

Further investigation of allopurinol effects on MPTP-induced oxidative stress in the striatum and brain stem of the rat

1 reference

12 December 2020

10.1007/S11910-012-0282-7

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

1038523046

0 references

1 reference